{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:48:23Z","timestamp":1793659703692,"version":"4.5.1"},"reference-count":90,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1053\/j.semdp.2023.09.001","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T21:04:46Z","timestamp":1695157486000},"page":"8-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pathology of hereditary renal cell carcinoma syndromes: Tuberous sclerosis complex (TSC)"],"prefix":"10.1053","volume":"41","author":[{"given":"Miranda E.","family":"Machacek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Lee","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9490-8583","authenticated-orcid":false,"given":"Kristine M.","family":"Cornejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1053\/j.semdp.2023.09.001_bib0001","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/path.4827","article-title":"New developments in the genetics and pathogenesis of tumours in tuberous sclerosis complex","volume":"241","author":"Lam","year":"2017","journal-title":"J Pathol"},{"key":"10.1053\/j.semdp.2023.09.001_bib0002","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0387-7604(94)00130-8","article-title":"History of the tuberous sclerosis complex","volume":"17","author":"Gomez","year":"1995","journal-title":"Brain Dev"},{"issue":"4","key":"10.1053\/j.semdp.2023.09.001_bib0003","first-page":"1201","article-title":"Tuberous sclerosis-associated renal cell carcinoma. Clinical, pathological, and genetic features","volume":"149","author":"Bjornsson","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1053\/j.semdp.2023.09.001_bib0004","series-title":"WHO Classification of Tumours","article-title":"Renal cell tumours: Introduction","author":"Raspolini","year":"2022"},{"issue":"10","key":"10.1053\/j.semdp.2023.09.001_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/genes12101585","article-title":"Renal cell carcinoma in tuberous sclerosis complex","volume":"12","author":"Henske","year":"2021","journal-title":"Genes (Basel)"},{"issue":"4","key":"10.1053\/j.semdp.2023.09.001_bib0006","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.molcel.2012.06.009","article-title":"TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1","volume":"47","author":"Dibble","year":"2012","journal-title":"Mol Cell"},{"issue":"9","key":"10.1053\/j.semdp.2023.09.001_bib0007","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tcb.2015.06.002","article-title":"Regulation of mTORC1 by PI3K signaling","volume":"25","author":"Dibble","year":"2015","journal-title":"Trends Cell Biol"},{"issue":"4","key":"10.1053\/j.semdp.2023.09.001_bib0008","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"International tuberous sclerosis complex consensus G. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational tuberous sclerosis complex consensus conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1053\/j.semdp.2023.09.001_bib0009","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pediatrneurol.2021.07.011","article-title":"Updated international tuberous sclerosis complex diagnostic criteria and surveillance and management recommendations","volume":"123","author":"Northrup","year":"2021","journal-title":"Pediatr Neurol"},{"issue":"8","key":"10.1053\/j.semdp.2023.09.001_bib0010","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1212\/01.WNL.0000142039.14522.1A","article-title":"Subependymal giant cell tumors in tuberous sclerosis complex","volume":"63","author":"Goh","year":"2004","journal-title":"Neurology"},{"issue":"4","key":"10.1053\/j.semdp.2023.09.001_bib0011","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF03033764","article-title":"Subependymal giant cell astrocytoma\u2013A clinicopathological study of 23 cases with special emphasis on histogenesis","volume":"10","author":"Sharma","year":"2004","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"10.1053\/j.semdp.2023.09.001_bib0012","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.3171\/foc.2006.20.1.6","article-title":"Imaging characteristics and growth of subependymal giant cell astrocytomas","volume":"20","author":"Clarke","year":"2006","journal-title":"Neurosurg Focus"},{"issue":"12","key":"10.1053\/j.semdp.2023.09.001_bib0013","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/neuonc\/nos257","article-title":"The molecular biology of WHO grade I astrocytomas","volume":"14","author":"Marko","year":"2012","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1053\/j.semdp.2023.09.001_bib0014","doi-asserted-by":"crossref","first-page":"128","DOI":"10.5414\/NP300818","article-title":"Consistent nuclear expression of thyroid transcription factor 1 in subependymal giant cell astrocytomas suggests lineage-restricted histogenesis","volume":"34","author":"Hewer","year":"2015","journal-title":"Clin Neuropathol"},{"issue":"3","key":"10.1053\/j.semdp.2023.09.001_bib0015","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/modpathol.2016.205","article-title":"Thyroid transcription factor-1 distinguishes subependymal giant cell astrocytoma from its mimics and supports its cell origin from the progenitor cells in the medial ganglionic eminence","volume":"30","author":"Hang","year":"2017","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2023.09.001_bib0016","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1227\/01.NEU.0000249216.19591.5D","article-title":"Subependymal giant-cell astrocytomas in pediatric tuberous sclerosis disease: When should we operate?","volume":"60","author":"de Ribaupierre","year":"2007","journal-title":"Neurosurgery"},{"issue":"6","key":"10.1053\/j.semdp.2023.09.001_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158476","article-title":"Long-term use of everolimus in patients with tuberous sclerosis complex: Final results from the EXIST-1 study","volume":"11","author":"Franz","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1053\/j.semdp.2023.09.001_bib0018","first-page":"98","article-title":"Trends in survival and treatment of SEGA: National cancer database analysis","volume":"8","author":"Ryoo","year":"2021","journal-title":"Neurooncol Pract"},{"issue":"8","key":"10.1053\/j.semdp.2023.09.001_bib0019","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/DAD.0000000000001083","article-title":"Fibrous papule: A histopathologic review","volume":"40","author":"Damman","year":"2018","journal-title":"Am J Dermatopathol"},{"issue":"4","key":"10.1053\/j.semdp.2023.09.001_bib0020","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1600-0560.1991.tb01237.x","article-title":"Fibrous papule of the nose with granular cells: two cases","volume":"18","author":"Guitart","year":"1991","journal-title":"J Cutan Pathol"},{"issue":"9","key":"10.1053\/j.semdp.2023.09.001_bib0021","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/j.1468-3083.2007.02160.x","article-title":"Fibrous papule of the face, clear cell type: a case report","volume":"21","author":"Park","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1053\/j.semdp.2023.09.001_bib0022","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1600-0560.2008.01038.x","article-title":"Clear cell fibrous papule: report of a case mimicking a balloon cell nevus","volume":"36","author":"Chiang","year":"2009","journal-title":"J Cutan Pathol"},{"issue":"6","key":"10.1053\/j.semdp.2023.09.001_bib0023","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.0303-6987.2005.00362.x","article-title":"Histologic variants of fibrous papule","volume":"32","author":"Bansal","year":"2005","journal-title":"J Cutan Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2023.09.001_bib0024","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1186\/s13023-022-02496-2","article-title":"Characterization and management of facial angiofibroma related to tuberous sclerosis complex in the United States: retrospective analysis of the natural history database","volume":"17","author":"Boggarapu","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"10.1053\/j.semdp.2023.09.001_bib0025","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/jdv.18693","article-title":"Analysis of current data on the use of topical mTOR inhibitors in the treatment of facial angiofibromas in tuberous sclerosis complex-An update","volume":"37","author":"Balestri","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1053\/j.semdp.2023.09.001_bib0026","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/ajmg.1320370402","article-title":"Incidence of tuberous sclerosis in patients with cardiac rhabdomyoma","volume":"37","author":"Harding","year":"1990","journal-title":"Am J Med Genet"},{"issue":"6","key":"10.1053\/j.semdp.2023.09.001_bib0027","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001493","article-title":"Cardiovascular manifestations of tuberous sclerosis complex and summary of the revised diagnostic criteria and surveillance and management recommendations from the International tuberous sclerosis consensus group","volume":"3","author":"Hinton","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1053\/j.semdp.2023.09.001_bib0028","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1017\/S1047951108002783","article-title":"Resection of ventricular rhabdomyomas in infants presenting with cardiac failure","volume":"18","author":"Dereddy","year":"2008","journal-title":"Cardiol Young"},{"key":"10.1053\/j.semdp.2023.09.001_bib0029","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-212946","article-title":"Rapid resolution of cardiac rhabdomyomas following everolimus therapy","author":"Choudhry","year":"2015","journal-title":"BMJ Case Rep"},{"issue":"6","key":"10.1053\/j.semdp.2023.09.001_bib0030","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0002-8703(97)70032-2","article-title":"Pediatric primary benign cardiac tumors: A 15-year review","volume":"134","author":"Beghetti","year":"1997","journal-title":"Am Heart J"},{"issue":"7","key":"10.1053\/j.semdp.2023.09.001_bib0031","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.crad.2011.02.009","article-title":"Radiological evidence of lymphangioleiomyomatosis in female and male patients with tuberous sclerosis complex","volume":"66","author":"Adriaensen","year":"2011","journal-title":"Clin Radiol"},{"issue":"11","key":"10.1053\/j.semdp.2023.09.001_bib0032","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.rmed.2012.07.007","article-title":"Cystic lung disease is not uncommon in men with tuberous sclerosis complex","volume":"106","author":"Ryu","year":"2012","journal-title":"Respir Med"},{"issue":"3","key":"10.1053\/j.semdp.2023.09.001_bib0033","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/ajmg.c.31638","article-title":"Pulmonary manifestations in tuberous sclerosis complex","volume":"178","author":"Gupta","year":"2018","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"11","key":"10.1053\/j.semdp.2023.09.001_bib0034","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S2213-2600(21)00228-9","article-title":"Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management","volume":"9","author":"McCarthy","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1053\/j.semdp.2023.09.001_bib0035","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/modpathol.3880359","article-title":"Multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis with a TSC2 gene","volume":"14","author":"Maruyama","year":"2001","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1053\/j.semdp.2023.09.001_bib0036","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/modpathol.2010.114","article-title":"Loss of heterozygosity on tuberous sclerosis complex genes in multifocal micronodular pneumocyte hyperplasia","volume":"23","author":"Hayashi","year":"2010","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1053\/j.semdp.2023.09.001_bib0037","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1097\/00000478-199311000-00002","article-title":"Transbronchial biopsy in lymphangiomyomatosis of the lung. HMB45 for diagnosis","volume":"17","author":"Bonetti","year":"1993","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2023.09.001_bib0038","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00408-012-9419-3","article-title":"Clinical predictors of mortality and cause of death in lymphangioleiomyomatosis: A population-based registry","volume":"191","author":"Oprescu","year":"2013","journal-title":"Lung"},{"issue":"17","key":"10.1053\/j.semdp.2023.09.001_bib0039","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1053\/j.semdp.2023.09.001_bib0040","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41581-018-0059-6","article-title":"Renal disease in tuberous sclerosis complex: Pathogenesis and therapy","volume":"14","author":"Lam","year":"2018","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"10.1053\/j.semdp.2023.09.001_bib0041","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.mayocp.2020.11.004","article-title":"Renal Neoplasia in tuberous sclerosis: A study of 41 patients","volume":"96","author":"Gupta","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.semdp.2023.09.001_bib0042","doi-asserted-by":"crossref","first-page":"972","DOI":"10.3389\/fneur.2020.00972","article-title":"Renal manifestations of tuberous sclerosis complex: Key findings from the final analysis of the TOSCA study focussing mainly on renal angiomyolipomas","volume":"11","author":"Kingswood","year":"2020","journal-title":"Front Neurol"},{"issue":"16","key":"10.1053\/j.semdp.2023.09.001_bib0043","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15164043","article-title":"Recent advances in renal tumors with TSC\/mTOR pathway abnormalities in patients with tuberous sclerosis complex and in the sporadic setting","volume":"15","author":"Kapur","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1053\/j.semdp.2023.09.001_bib0044","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ng1294-328","article-title":"Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease\u2013A contiguous gene syndrome","volume":"8","author":"Brook-Carter","year":"1994","journal-title":"Nat Genet"},{"key":"10.1053\/j.semdp.2023.09.001_bib0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1746-1596-2-11","article-title":"Angiomyolipoma with epithelial cysts (AMLEC): A rare but distinct variant of angiomyolipoma","volume":"2","author":"Armah","year":"2007","journal-title":"Diagn Pathol"},{"issue":"5","key":"10.1053\/j.semdp.2023.09.001_bib0046","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.pas.0000194298.19839.b4","article-title":"Angiomyolipoma with epithelial cysts (AMLEC): A distinct cystic variant of angiomyolipoma","volume":"30","author":"Fine","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1053\/j.semdp.2023.09.001_bib0047","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006242","article-title":"Whole exome sequencing identifies TSC1\/TSC2 biallelic loss as the primary and sufficient driver event for renal angiomyolipoma development","volume":"12","author":"Giannikou","year":"2016","journal-title":"PLoS Genet"},{"issue":"2","key":"10.1053\/j.semdp.2023.09.001_bib0048","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/PAS.0b013e31817ed7a6","article-title":"Renal angiomyolipoma: Clinicopathologic study of 194 cases with emphasis on the epithelioid histology and tuberous sclerosis association","volume":"33","author":"Aydin","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1053\/j.semdp.2023.09.001_bib0049","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/PAS.0b013e3181d90370","article-title":"Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy","volume":"34","author":"Brimo","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2023.09.001_bib0050","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/PAS.0b013e318206f2a9","article-title":"Pure epithelioid PEComas (so-called epithelioid angiomyolipoma) of the kidney: A clinicopathologic study of 41 cases: detailed assessment of morphology and risk stratification","volume":"35","author":"Nese","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1053\/j.semdp.2023.09.001_bib0051","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2559.2009.03420.x","article-title":"Renal epithelioid angiomyolipoma: A study of six cases and a meta-analytic study. Development of criteria for screening the entity with prognostic significance","volume":"55","author":"Faraji","year":"2009","journal-title":"Histopathology"},{"issue":"10","key":"10.1053\/j.semdp.2023.09.001_bib0052","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/modpathol.2013.72","article-title":"Epithelioid angiomyolipoma of the kidney: Pathological features and clinical outcome in a series of consecutively resected tumors","volume":"26","author":"He","year":"2013","journal-title":"Mod Pathol"},{"issue":"8","key":"10.1053\/j.semdp.2023.09.001_bib0053","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1158\/2159-8290.CD-17-0151","article-title":"AACR project GENIE: Powering precision medicine through an international consortium","volume":"7","author":"Consortium","year":"2017","journal-title":"Cancer Discov"},{"issue":"2","key":"10.1053\/j.semdp.2023.09.001_bib0054","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.urolonc.2021.09.010","article-title":"Clinical and pathological features of renal epithelioid angiomyolipoma (PEComa): A single institution series","volume":"40","author":"Saoud","year":"2022","journal-title":"Urol Oncol"},{"issue":"7","key":"10.1053\/j.semdp.2023.09.001_bib0055","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/PAS.0000000000000237","article-title":"Renal cell carcinoma in tuberous sclerosis complex","volume":"38","author":"Yang","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1053\/j.semdp.2023.09.001_bib0056","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/PAS.0000000000000248","article-title":"Tuberous sclerosis-associated renal cell carcinoma: A clinicopathologic study of 57 separate carcinomas in 18 patients","volume":"38","author":"Guo","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2023.09.001_bib0057","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.humpath.2022.09.001","article-title":"Lessons from histopathologic examination of nephrectomy specimens in patients with tuberous sclerosis complex: Cysts, angiomyolipomas, and renal cell carcinoma","volume":"129","author":"Gupta","year":"2022","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2023.09.001_bib0058","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2021.06.002","article-title":"Co-existence of ESC-RCC, EVT, and LOT as synchronous and metachronous tumors in six patients with multifocal neoplasia but without clinical features of tuberous sclerosis complex","volume":"116","author":"Lerma","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2023.09.001_bib0059","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.humpath.2017.11.013","article-title":"Renal cell carcinoma with angioleiomyoma-like stroma and clear cell papillary renal cell carcinoma: Exploring SDHB protein immunohistochemistry and the relationship to tuberous sclerosis complex","volume":"75","author":"Williamson","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2023.09.001_bib0060","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.humpath.2022.12.015","article-title":"TSC\/MTOR mutated renal cell carcinoma with leiomyomatous stroma is a distinct entity: A comprehensive study of 12 cases","volume":"134","author":"Tjota","year":"2023","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1053\/j.semdp.2023.09.001_bib0061","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/PAS.0000000000001422","article-title":"\"Renal cell carcinoma with leiomyomatous stroma\" Harbor somatic mutations of TSC1, TSC2, MTOR, and\/or ELOC (TCEB1): Clinicopathologic and molecular characterization of 18 sporadic tumors supports a distinct entity","volume":"44","author":"Shah","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2023.09.001_bib0062","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/modpathol.2014.105","article-title":"Renal cell carcinoma with angioleiomyoma-like stroma: Clinicopathological, immunohistochemical, and molecular features supporting classification as a distinct entity","volume":"28","author":"Williamson","year":"2015","journal-title":"Mod Pathol"},{"issue":"10","key":"10.1053\/j.semdp.2023.09.001_bib0063","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2208::AID-CNCR21>3.0.CO;2-K","article-title":"Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex","volume":"83","author":"Al-Saleem","year":"1998","journal-title":"Cancer"},{"issue":"3","key":"10.1053\/j.semdp.2023.09.001_bib0064","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/cjp2.104","article-title":"Atypical tuberous sclerosis complex presenting as familial renal cell carcinoma with leiomyomatous stroma","volume":"4","author":"Bah","year":"2018","journal-title":"J Pathol Clin Res"},{"issue":"8","key":"10.1053\/j.semdp.2023.09.001_bib0065","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1097\/PAS.0000000000001255","article-title":"Genetic Underpinnings of renal cell carcinoma with leiomyomatous stroma","volume":"43","author":"Parilla","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1053\/j.semdp.2023.09.001_bib0066","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/s41379-021-00779-w","article-title":"New developments in existing WHO entities and evolving molecular concepts: The genitourinary pathology society (GUPS) update on renal neoplasia","volume":"34","author":"Trpkov","year":"2021","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1053\/j.semdp.2023.09.001_bib0067","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/modpathol.2015.6","article-title":"TCEB1-mutated renal cell carcinoma: A distinct genomic and morphological subtype","volume":"28","author":"Hakimi","year":"2015","journal-title":"Mod Pathol"},{"issue":"8","key":"10.1053\/j.semdp.2023.09.001_bib0068","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100194","article-title":"Biallelic ELOC-inactivated renal cell carcinoma: Molecular features supporting classification as a distinct entity","volume":"36","author":"Batavia","year":"2023","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2023.09.001_bib0069","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/PAS.0000000000000508","article-title":"Eosinophilic, solid, and cystic renal cell carcinoma: Clinicopathologic study of 16 unique, sporadic neoplasms occurring in women","volume":"40","author":"Trpkov","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1053\/j.semdp.2023.09.001_bib0070","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/PAS.0000000000001955","article-title":"TSC\/MTOR -associated eosinophilic renal tumors exhibit a heterogeneous clinicopathologic spectrum : A targeted next-generation sequencing and gene expression profiling study","volume":"46","author":"Xia","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2023.09.001_bib0071","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.eururo.2018.06.007","article-title":"Somatic Bi-allelic loss of TSC genes in eosinophilic solid and cystic renal cell carcinoma","volume":"74","author":"Mehra","year":"2018","journal-title":"Eur Urol"},{"issue":"3","key":"10.1053\/j.semdp.2023.09.001_bib0072","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41379-021-00816-8","article-title":"TSC loss is a clonal event in eosinophilic solid and cystic renal cell carcinoma: a multiregional tumor sampling study","volume":"35","author":"Munari","year":"2022","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1053\/j.semdp.2023.09.001_bib0073","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/PAS.0000000000001111","article-title":"Eosinophilic solid and cystic (ESC) renal cell carcinomas harbor TSC mutations: molecular analysis supports an expanding clinicopathologic spectrum","volume":"42","author":"Palsgrove","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1053\/j.semdp.2023.09.001_bib0074","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/his.13457","article-title":"Eosinophilic solid and cystic renal cell carcinomas have metastatic potential","volume":"72","author":"McKenney","year":"2018","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2023.09.001_bib0075","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.humpath.2018.05.023","article-title":"Eosinophilic solid and cystic renal cell carcinoma mimicking epithelioid angiomyolipoma: series of 4 primary tumors and 2 metastases","volume":"80","author":"Tretiakova","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2023.09.001_bib0076","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000002101","article-title":"Oncocytoid renal cell carcinomas after neuroblastoma\" Represent TSC-mutated eosinophilic solid and cystic renal cell carcinomas: Association with prior childhood malignancy and multifocality with therapeutic implications","author":"Argani","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2023.09.001_bib0077","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.humpath.2021.04.013","article-title":"Low-grade oncocytic tumor of kidney (CK7-Positive, CD117-Negative): Incidence in a single institutional experience with clinicopathological and molecular characteristics","volume":"114","author":"Kravtsov","year":"2021","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2023.09.001_bib0078","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/his.13865","article-title":"Low-grade oncocytic tumour of kidney (CD117-negative, cytokeratin 7-positive): A distinct entity?","volume":"75","author":"Trpkov","year":"2019","journal-title":"Histopathology"},{"issue":"3","key":"10.1053\/j.semdp.2023.09.001_bib0079","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00428-020-02927-0","article-title":"Characterization of a distinct low-grade oncocytic renal tumor (CD117-negative and cytokeratin 7-positive) based on a tertiary oncology center experience: The new evidence from China","volume":"478","author":"Guo","year":"2021","journal-title":"Virchows Arch"},{"issue":"11","key":"10.1053\/j.semdp.2023.09.001_bib0080","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/jclinpath-2021-207478","article-title":"Low-grade oncocytic tumour expands the spectrum of renal oncocytic tumours and deserves separate classification: A review of 23 cases from a single tertiary institute","volume":"75","author":"Akgul","year":"2022","journal-title":"J Clin Pathol"},{"issue":"3","key":"10.1053\/j.semdp.2023.09.001_bib0081","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/s41379-021-00906-7","article-title":"Low-grade oncocytic renal tumor (LOT): Mutations in mTOR pathway genes and low expression of FOXI1","volume":"35","author":"Morini","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2023.09.001_bib0082","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2023.1610852","article-title":"Low-grade oncocytic tumour (LOT) of the kidney is characterised by GATA3 positivity, FOXI1 negativity and mTOR pathway mutations","volume":"29","author":"Chen","year":"2023","journal-title":"Pathol Oncol Res"},{"issue":"3","key":"10.1053\/j.semdp.2023.09.001_bib0083","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41379-021-00896-6","article-title":"Germline and sporadic mTOR pathway mutations in low-grade oncocytic tumor of the kidney","volume":"35","author":"Kapur","year":"2022","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1053\/j.semdp.2023.09.001_bib0084","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00428-018-2456-4","article-title":"High-grade oncocytic renal tumor\": morphologic, immunohistochemical, and molecular genetic study of 14 cases","volume":"473","author":"He","year":"2018","journal-title":"Virchows Arch"},{"issue":"1","key":"10.1053\/j.semdp.2023.09.001_bib0085","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/PAS.0000000000001170","article-title":"Somatic Mutations of TSC2 or MTOR characterize a morphologically distinct subset of sporadic renal cell carcinoma with eosinophilic and vacuolated cytoplasm","volume":"43","author":"Chen","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2023.09.001_bib0086","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/PAP.0000000000000299","article-title":"Eosinophilic vacuolated tumor of the kidney: A review of evolving concepts in this novel subtype with additional insights from a case with MTOR mutation and concomitant chromosome 1 loss","volume":"28","author":"Kapur","year":"2021","journal-title":"Adv Anat Pathol"},{"key":"10.1053\/j.semdp.2023.09.001_bib0087","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.humpath.2020.12.006","article-title":"TSC\/MTOR-mutated eosinophilic renal tumors are a distinct entity that is CK7+\/CK20-\/vimentin-: A validation study","volume":"115","author":"Tjota","year":"2021","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1053\/j.semdp.2023.09.001_bib0088","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/his.13876","article-title":"High-grade oncocytic tumour (HOT) of kidney in a patient with tuberous sclerosis complex","volume":"75","author":"Trpkov","year":"2019","journal-title":"Histopathology"},{"issue":"3","key":"10.1053\/j.semdp.2023.09.001_bib0089","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41379-021-00923-6","article-title":"Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC\/MTOR mutations: Next-generation sequencing multi-institutional study of 19 cases","volume":"35","author":"Farcas","year":"2022","journal-title":"Mod Pathol"},{"issue":"10","key":"10.1053\/j.semdp.2023.09.001_bib0090","first-page":"1257","article-title":"Renal hybrid oncocytic\/chromophobe tumors - A review","volume":"28","author":"Hes","year":"2013","journal-title":"Histol Histopathol"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074025702300093X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074025702300093X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:24:22Z","timestamp":1760037862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074025702300093X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S074025702300093X"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2023.09.001","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathology of hereditary renal cell carcinoma syndromes: Tuberous sclerosis complex (TSC)","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2023.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}